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CHAPTER I
MATERIALS AND METHODS
Acquisition of Hoof Lamellar Samples
This has been described (Johnson, Kreeger et al. 2000; Loftus, Belknap et
al. 2006). For BWE and starch induced laminitis, horses were anesthetized
(Johnson, Kreeger et al. 2000; Loftus, Belknap et al. 2006; Loftus, Belknap et al.
2007), the distal aspect of the right fore limb disarticulated from each horse at the
level of the metacarpophalangeal joint and acquisition of lamellar tissue from
each hoof accomplished within 5 minutes using a band saw, Horses were
euthanized immediately after removal of the hoof. For clinical samples, lamellae
were isolated with 10 minutes of euthanasia. Blocks of lamellar tissue
(approximately 5 mm X 5 mm) were obtained by sharp dissection and either
placed in 10% formalin or immediately frozen by submersion in liquid nitrogen
and stored at -80° C until processed. In all cases blocks of lamellar tissue were
obtained from the mid-point between the level of the coronary band
and the ground- bearing surface on the dorsal aspect of the hoof.
BWE Samples
Archived samples of laminar tissue from previous studies (Waguespack,
Cochran et al. 2004; Waguespack, Kemppainen et al. 2004; Black, Lunn et al.
2006) were used. Briefly, healthy horses were administered either 6 L of water as
a control (n = 10) or BWE (n = 10) (2 g heartwood/kg body weight, prepared as
described (Eaton et al., 1995) via nasogastric intubation. Horses were euthanized
at 1.5 hours post-induction, after a 30 % drop in the baseline leukocyte count (3 to
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5 hours after BWE), or at the onset of Obel grade 1 lameness (typically around
10-12 hours after BWE). All animal protocols were approved by the Institutional
Animal Care and Use Committees (IACUCs) of the Ohio State University or
Auburn University.
CHO Samples
Carbohydrate-treated animals: Archived samples of lamellae from a
previous study (Johnson, Kreeger et al. 2000) were used. Briefly, healthy horses
were administered starch at a concentration of 17.6 grams of starch per kg of body
weight via a nasogastric tube as described or water as a control (Johnson, Kreeger
et al. 2000). Horses were euthanized when they developed Obel grade III laminitis
(experimental group) typically 36 to 48 hours following administration of starch,
or at equivalent time points for control animals. All animal protocols were
approved by the IACUC of the University of Missouri.
Clinical Samples
These were obtained from horses euthanized at the University of Missouri
School of Veterinary Medicine Equine Clinical Center. Animals were grouped as
follows: Those presenting “acute clinical laminitis” had not previously shown
signs of this disease; those presenting “chronic clinical laminitis” had a history of
the condition and were chronically lame but not in an acute episode; those
presenting “chronic aggravated laminitis” had a history of the condition and were
experiencing a debilitating episode. Control clinical samples were from horses
euthanized for a variety of conditions unrelated to laminitis and had no history of
laminitis.
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RNA Isolation and cDNA Synthesis
Black Walnut Extract laminae were pulverized using a tissue
homogenizer. Total RNA was then extracted from the tissue using the
guanidinium isothiocynate method as described in (Alfandari, Whittaker et al.
1995). RNA was quantified at OD260 and 1µg of each sample was run on a 1%
agarose gel with 0.1µg/ml ethidium bromide to ensure RNA integrity. Using 0.5 g
of frozen laminae tissue and 10 ml of guanidinium isothiocynate solution we
obtained 25-160 µg of RNA depending on sample. 10 µg of this RNA was treated
by RNAse free DNAse 1 (Promega) prior to cDNA synthesis reaction using oligo
dT and MMLV reverse transcriptase in a 50 µl reaction volume (Promega).
Before addition of the MMLV, 10 µl of the reaction mix was removed and saved
for the no-RT control PCR and to control for complete genomic DNA digestion.
This cDNA was then diluted in sterile H2O 1:10 and 1 µl of this dilution was used
for each 20 µl RT-qPCR reaction. Total RNA was also extracted from frozen
equine testis tissue using a tissue homogenizer. Using 100 mg of tissue we were
able to extract approximately 70 µg of total RNA. cDNA synthesis was done
using the same method used for the BWE treated animals. The cDNA for the
clinical and Carbohydrate Overload samples were obtained as previously
described (Waguespack, Cochran et al. 2004; Waguespack, Kemppainen et al.
2004).
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RT-qPCR and Data Processing
The quantitative PCR data was obtained using the Roche Lightcycler 2.0.
Each primer set was tested in order to determine the melting curve of the
amplification product which was then used to determine the optimal fluorescence
reading temperature. The reading temperature for each primer set was selected at
2-4°C before complete dissociation of the specific amplification product.
Following each reaction, PCR products were run on 2% agarose gel with
0.1µg/ml ethidium bromide to confirm that the proper size fragment was
amplified for each product. Cycling conditions were as follows: 1 cycle at 95°C
for 5 minutes, 45 cycles of 60°C for 30s, 72°C for 30s, single fluorescence
reading at predetermined temperature, 95° C for 15s, 1 cycle for melting curve
using a stepwise increase of temperature from 65°C to 95°C with a constant
fluorescence reading. In order to determine the most stable control gene for
comparison using the ∆∆Ct method we used the GeNorm computer program
(Ghent University). We tested the expression patterns of Glyceraldeyhde 3phosphate dehydrogenase (GAPDH), β-Actin, and α2-Microglobulin and the
most stable control gene in both the BWE and CHO/Clinical laminitis sets was
determined to be GAPDH and was used as our control. Each sample was then run
in triplicate and their Ct values were averaged and analyzed using the ∆∆Ct
method of analysis (Livak and Schmittgen 2001). The results from this analysis
for the control animals were averaged separately for animals from the BWE
subset (n=3) and animals from the CHO/Clinical laminitis subsets (n=4).
Experimental results for each animal and gene were then divided by the average
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of the control animals to produce a final fold increase controlled both to GAPDH
and to animals that did not show signs of laminitis.
Cloning of ADAMs
Testis cDNA was used as template to amplify ADAM related
metalloprotease as well as TIMPs by RT-PCR using the minimally degenerated
oligonucleotides found in Table 3. Cycling conditions for all genes were: 1 cycle
at 95°C for 4 minutes, 35 cycles of 94°C 30 seconds, 55°C 30 seconds, 72°C 1
minute, 1 cycle 72°C for 5 minutes. Using equine testis cDNA as a template each
genes correct product size was amplified. These PCR products were cloned into
pCR4-TOPO (Invitrogen) and

sequenced

either by the university of

Massachusetts Amherst genomic facility or the Genewiz company. These
sequences were then analyzed using BLAST and upon confirmation of each genes
identity, specific primers were designed for real time quantitative PCR.
Degenerate oligonucleotides were also employed to clone full-length constructs of
both MMP9 and ADAM-TS4.
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CHAPTER II
HISTORY OF LAMINITIS
Introduction to Laminitis
Laminitis is defined as an inflammation of the laminae, especially in the
hoof of the horse (Merriam Webster). It is a disease that has affected the equine
industry since as early as 350 B.C. when Aristotle termed it ‘Barley Disease’.
Since this time there have been many treatments developed for the disease,
including treatment with anti-inflammatory drugs, NSAIDs, and ice baths. All of
these treatments are capable of helping to treat the symptoms, but none target the
underlying systemic issues. In recent years work has been done to understand
exactly how the equine hoof responds to laminitis and what structures are being
affected. It is critical to determine what the molecular pathologies are during the
initiating and developmental stages of laminitis in order to develop a treatment
that has any potential for success.

Anatomical Evolution of the Horse
The horse evolved over a 60 million years into an animal that man kind
has relied on to help spread onto every corner of the planet. The original animal
was termed Hyracotherium and its unique characteristics allowed for its
development into the animal that we now know as the modern Equus Caballus
(Short 1975). The forelimbs of the modern horses predecessor had five padded
toes, named p1 through p5, while the hind limbs had only three padded toes,
named p1 through p3.
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As evolution selected for the strongest of this animals traits, the forelimbs
drastically changed. Over a period of about 50 million years the horse had
evolved into an animal known as Pliohippus which had evolved such that the only
weight bearing toe was p3 (Short 1975). Over the next 10 million years the horse
evolved slightly further and the only clearly digit that is visible to date is the p3
bone. Both p4, the metatarsal bone, and p2, the metacarpal bone are still present
and are termed the splint bones. These bones play an important role in supporting
the knee and hock in Equus Caballus (Short 1975).
Evolution has clearly shown that perhaps the most important bone in a
horses body is the p3 digit. This bone is solely responsible for the support of the
animals entire mass, which averages around 1000 pounds. It also has to be taken
into account that the force of impact on the forelimbs greatly exceeds that of the
animals body weight. Inflammation and degradation of the sensitive laminae,
which connects the p3 bone to the inner wall of the hoof is the major cause of
laminitis and a great deal of work has been done to study how this connection is
made. The connection between the keratinized hoof wall and the p3 digit can be
divided into three sections, the coronary papillae, secondary lamellae, and
terminal papillae, as seen in Figure 1.
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Figure 1: Anatomy of the Hoof Wall (Daradka and Pollitt 2004; Pollitt and
Daradka 2004; Keller, Galloway et al. 2006)
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The corium, located at the top of the hoof wall is a highly vascular area
consisting of tough connective tissue with a network of arteries, veins, and
capillaries. It is essential for nourishment of the hoof and it plays a major role in
the connection of the p3 digit with the inner hoof. Each coronary papillae that
shoots out from the corium is responsible for providing nutrients to an individual
hoof wall tubule (Kasapi and Gosline 1998). As epidermal basal cells produce
keratinocytes they are targeted in a downward path towards the bottom of the
hoof wall (Daradka and Pollitt 2004). This is how the hoof is able to grow
constantly through the life of a horse.
Moving distally in the hoof, the next major region of importance for
support is the secondary lamellae. Within this region is the stratum lamellatum
which has several hundred projecting primary epidermal lamellae. These
epidermal lamellae are shaped like long rectangles and they are incorporated into
the stratum lamellatum like a key in a lock. It is believed that the structure of the
epidermal lamellae is intended to increase the surface area of the lamellae which
suggests its potential role in the suspension of the animals weight (Sarratt and
Hood 2005). Overall the entire surface area of the inner hoof wall has been
calculated to average 1.3m2 which is equal to that of the surface area of a humans
entire skin (Sarratt and Hood 2005). With this amazing surface area the animal is
able to deal with the great deal of stress placed on the hoof in both active and
stationary activities.
In the location where the epidermis and dermis meet, there is a very tough
sheet of extracellular matrix known as the basement membrane. This structure
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attaches the cells of the lamellar epidermis to type I collagen on the surface of the
p3 bone (Pollitt and Daradka 1998). Filaments of collagen IV run in the dorsalventral axis and are covered in laminin, these two together form the laminin densa
(Pollitt 1994). Type I collagen and laminin densa interweave and are found at a
high concentration in the basement membrane (Pollitt 1994) which is not
surprising considering the weight bearing load of the hoof.

Conflicting Hypothesis on the Cause of Laminitis
At this point in time there are two main hypotheses on how laminitis
manifests itself. The first hypothesis suggests that constriction of the blood
vessels supplying nutrients to the collagen rich laminae become restricted,
causing cell death in the laminae (Hood 1999). The second hypothesis proposes
that a local inflammation of the laminae recruits leucocytes that activate MMPs
and initiate the destruction of the laminae (Johnson, Tyagi et al. 1998; Mungall,
Pollitt et al. 1998). This second hypothesis has been supported in recent findings
where horses induced with Black Walnut Extract showed proteolytic fragments of
collagen in their blood (Johnson, Kreeger et al. 2000). Other recent work has
shown an infiltration of neutrophils into the laminae which correlates with an
increased level of MMP-9 protein (Loftus, Belknap et al. 2006). This would most
likely occur because neutrophils have been observed to store MMP-9 in their
tertiary granules (Chakrabarti and Patel 2005).
Regardless of the initial triggering mechanism the end result is always the
destruction of the collagen rich laminae. It is interesting to note that both ischemia
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and inflammation can result in the activation of metalloproteases capable of
degrading the collagen rich laminae.
Natural Laminitis Description
Causes of natural laminitis have such a great range that it is very hard to
pin point what started the disease. Many of the potential causes are outlined in
Table 1.
Cause
Carbohydrate
Overload

Insulin Resistance
Nitrogen
Compound
Overload
Hard Ground
Lush Pastures
Colic

Reasoning
If a horse is given grain in excess or eats grass under
stress and has accumulated excess of non-structural
carbohydrates it may be unable to digest the
carbohydrates in the foregut. Excess carbohydrates
move to the hindgut and ferment in the cecum. This
causes an increase in lactic acid levels and proliferation
of bacteria capable of producing endotoxins. Endotoxins
are absorbed into the bloodstream resulting in a
decreased circulation, especially in the hoof.
Not fully understood but may be triggered by sugar and
starch imbalance.
Rapid fluctuation of non-protein nitrogens. The natural
metabolic processes become overloaded resulting in
liver disturbance and toxic imbalance.
Hard surfaces increase concussion on horses feet,
potentially causing laminitis.
Same concept as carbohydrate overload.
Release of endotoxins into the blood stream
Table 1: Causes of Laminitis

The progression of laminitis has been divided into four stages. The
developmental (prodromal) stage begins when an initial injury occurs until there
is an appearance of the clinical signs of laminitis (Hood, Grosenbaugh et al.
1993). The duration of this phase depends mainly on what factor caused the initial
injury, for example Black Walnut ingestion will cause a shorter developmental
stage than colic. The next stage is the acute phase lasting from when clinical signs
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are observed until there is evidence of mechanical collapse of the distal phalanx
within the hoof capsule, or 72 hours, whichever comes first (Hood 1999). If there
are clinical signs over 72 hours but there is not structural failure of the hoof the
disease is classified as sub acute. Once the horse develops structural failure, for
example rotation or sinking of the distal phalanx, then the disease is considered in
the chronic phase.
These stages are also linked to the Obel grading system of laminitis,
which was developed by Obel in 1948 (Obel N. Studies on the histopathology of
acute laminitis. Uppsala, Sweden: Almquist and Wiskells, 1948.). This system
grades a horse symptom from 1 through 4, with 4 being the worst prognosis. At
grade 1 a horse alternately and incessantly lifts the feet, lameness is not evident at
a walk, but at a trot a short stilted gait is noticed. Grade 2 is defined as a horse
that walks with a stilted gait but can still have a foot lifted. The main difference at
grade 3 is that a horse moves much more reluctantly and will resist lifting of a
foot. At the most severe grade, grade 4, the horse refuses to move unless forced to
do so.
Induction models of Laminitis
Development of an experimental model for natural laminitis is essential in
attempting to study the molecular and pathological events leading up to the
degradation of the laminae. There are two current models used for the
experimental induction of laminitis, these are the Black Walnut (BWE) and
Carbohydrate Overload (CHO) models. Each model has its own benefits and
drawbacks, which have been explored extensively since their discovery.
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Induction of laminitis by treatment of Black Walnut extract via nasogastric
intubation was developed in the 1980’s (Minnick, Brown et al. 1987). It was
known in the horse industry that animals exposed to shavings from the black
walnut tree, Juglans Nigra, became laminitic. In order to confirm this hypothesis
Minneck soaked 2g/kg of black walnut shavings in water and administered it to
the animals via nasogastric intubation. In this experiment, horses developed
edema of the coronary band and 8/10 horses demonstrated clinical signs of
laminitis within 12 hours of administration (Minnick, Brown et al. 1987).
Measurements revealed at least a 30% decrease in white blood cell counts 4 hours
after administration of BWE, and an increase in white blood cells, packed cell
volume, and hyperglycemia starting at 8 hours post administration (Galey,
Whiteley et al. 1991). These changes in white blood cells are similar to that of
animals with endotoxemia but when blood from BWE induced horses was
analyzed for endotoxins there were none present (Eaton, Allen et al. 1995).
Another aspect of natural laminitis that is clearly necessary for any
relevant induction model is the inflammatory response. This is because it has been
noted that hoof wall temperature is increased in animals with both natural and
induced cases of laminitis (Baxter 1994). Work has been done to look at the
expression of IL-1β, an inflammatory cytokine, in the laminae of horses
administered BWE after approximately 3 hours (Fontaine, Belknap et al. 2001).
The results showed an increase in IL-1β which provided evidence of an
inflammatory response occurring early in the development of BWE laminitis.
Other pro-inflammatory cytokines such as IL-6 and IL-8 have been observed to be
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increased in the CHO and BWE models of laminitis, once again indicating that
laminitis in accompanied by an inflammatory response (Belknap, Giguere et al.
2007). These results have only been investigated in induction models of laminitis
and it is critical to see if these same results are found in animals with naturally
occurring laminitis.
The most commonly used methods for induction of laminitis by
Carbohydrate Overload was developed in 1975 (Garner, Coffman et al. 1975). A
laminitis inducing ratio of 85% corn startch and 15% wood cellulose flour was
administered at a dose of 17.6g/kg body weight via a stomach tube. It has been
observed that there is an alteration in cecal flora, lactic acidosis, and endotoxemia
after administration but the exact mechanism of laminitis induction is still
unknown (Garner, Moore et al. 1978; Moore, Garner et al. 1979; Krueger, Kinden
et al. 1986; Sprouse, Garner et al. 1987; Weiss, Evanson et al. 1998; Weiss,
Evanson et al. 2000). Obel Grade 3 lameness was observed approximately 40
hours post CHO treatment. Increased packed cell volume, leukocytosis, and
hyperproteinemia were all observed in these animals indicating a close relation to
natural laminitis (Coffman and Garner 1972; Harkema, Robinson et al. 1978;
Moore, Garner et al. 1981; Fagliari, McClenahan et al. 1998).
Examination of the hoofs histology in the CHO model has shown that
there is an initial alteration in the digital vasculature, including swelling of
endothelial cells and mild edema formation (Hood, Grosenbaugh et al. 1993).
After 6-12 hours of administration a leukocyte infiltration occurs that dissipates as
inflammatory cells are able to migrate to the epidermal layer. Microvascular
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thrombi and accompanying severe edema formation are seen after 24 hours, and
hemorrhage occurs in the primary dermal layer after 72 hours (Hood,
Grosenbaugh et al. 1993). It has also been observed that after 48 hours of CHO
treatment the lamellar basement membrane disintegrates and attachment of the
basement membrane to basal cells of the epidermis is gone (Pollitt 1996).
Treatment
To date there is no cure for laminitis but there are several treatment
options. In many cases rest and corrective shoeing is what an owner will do to
curb a laminitic episode. Shoes will typically have pedal bone support to keep the
p3 bone in the proper position to aide readhesion. In many other cases analgesics
and vasodilators are used to relieve pain, reduce inflammation, and improve blood
flow to the hoof. It is thought that increasing blood flow to the hoof area will help
to speed the influx of repair enzymes to the area. Since there is no cure these
treatments are only supplementary to the animals own immune system which
overall has to take on the task of repairing any damage to the laminae.
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CHAPTER III
HISTORY OF ADAMs AND RELATED METALLOPROTEASES
ADAM discovery
The ADAM family of proteins was initially discovered as a cellular family
of proteins that share a common domain organization with the previously
discovered snake venom metalloproteases (Weskamp and Blobel 1994;
Wolfsberg, Primakoff et al. 1995).

Domain Organization
ADAMs are members of the zinc protease superfamily which is
subdivided based on their catalytic sites primary structure. This group of
metalloproteases belongs to the metzincin subfamily which is further divided into
adamlysins (matrixins belong to this family as well MMPs and ADAM-TS)
(Wolfsberg, Primakoff et al. 1995). The typical organization of an ADAM from
n-termini to c-termini is a signal sequence, a prodomain, metalloprotease domain,
disintegrin domain, cystine rich repeats, an EGF like domain and a
transmembrane domain with a cytoplasmic tail afterwards (Seals and Courtneidge
2003).
The ADAM-TS subfamily share a very similar organization to that of the
ADAMs with a signal sequence, prodomain, metalloprotease domain, disintegrin
domain followed by a single thrombospondin like domain followed by a cysteine
rich domain (Seals and Courtneidge 2003). This is then followed by varying
numbers of thrombospondin like repeats depending on the exact ADAM-TS being
discussed.
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MMPs, a group of metalloproteases belonging to the same family as the
adamlysins share a similar domain organization to that of ADAMs. Typical
organization for the MMPs is a signal sequence, a prodomain, metalloprotease
domain with fibronectin type II like repeats, and a hemopexin like domain (Seals
and Courtneidge 2003). A schematic representation of these domains can be
found in Figure 2.
TIMPs, the natural Tissue Inhibitors of Metalloproteases have four family
members, TIMP1-4. This family of proteins has two domains, an N-terminal
domain and a C-terminal domain (Woessner 2001). Each domain contains three
disulfide bridges and most of the biological functions reside in the N-terminal
domain (Brew, Dinakarpandian et al. 2000).

(Seals and Courtneidge 2003)
Figure 2 – Domain Organization of ADAM Family of Metalloproteases
Domains of the ADAMs and related metalloproteases. ADAMTS family members
have variable number of thrombospondin-like (TS) repeats. MMP shown is
representative of the gelatinase class (MMP-2 and 9).
Expression, Regulation, and Localization
The expression pattern of the ADAM family of proteins is greatly varied
with many of these proteins being expressed in the testis (Seals and Courtneidge
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2003). These proteins are thought to be synthesized in the rough ER and then go
on to mature in the late Golgi compartment (Lum, Wong et al. 1999; Hougaard,
Loechel et al. 2000; Howard, Maciewicz et al. 2000). It is while the protein is in
the late Golgi that the pro domain is thought to be cleaved, making the protein
competent to function. Cleavage of the pro domain can also occur at the cell
surface by furin-like proteases (Srour, Lebel et al. 2003). Metalloprotease activity
of ADAMs 10, 17, and 19 can occur within intracellular compartments
(Skovronsky, Moore et al. 2000; Shirakabe, Wakatsuki et al. 2001). With all of
these differences in localization it is presumed that the localization and activity of
ADAMs depends on the cell type, substrates, and which ADAM is interacting.
The ADAM-TS family of proteins has been shown to localize within the
ECM. This localization is mediated via the thrombospondin (TSP) repeats which
can bind to ECM components. The tissue distribution for each ADAMTS family
member is wide spread in normal adult tissues. A table of the ADAM-TS genes of
interest in laminitis and their tissue localizations in humans can be found below in
Table 2. The regulation of this gene family is not very well understood but there is
some evidence suggesting that many of these family members are regulated by
growth factors, hormones and inflammatory cytokines (Miles, Sluka et al. 2000;
Wang, Wang et al. 2003; Kashiwagi, Enghild et al. 2004).
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Gene
ADAM-TS1

Fetal Tissue
Kidney, Lung

Normal Adult Tissue
Heart, Placenta, Liver, Skeletal Muscle,
Kidney, Thyroid, Adrenal Cortex, Stomach,
Bladder, Aorta, Colon, Prostate, Spinal Cord

ADAM-TS4

Not tested

Bladder, Brain, Ovary, Heart, Skeletal muscle,
Uterus, Stomach, Spinal cord

ADAM-TS5

Not tested

Bladder, Cervix, Oesophagus, Placenta, Uterus

Table 2: Localization of ADAMTS Gene Expression. Adapted from (Porter, Clark
et al. 2005)
Matrix Metalloproteases expression is mostly ubiquitous and therefore
these enzyme are involved in many physiological processes (tissue remodeling in
pregnancy, wound healing, and angiogenesis) and pathological conditions
(cancer, arthritis, periodontitis) (Yan and Boyd 2007). These metalloproteases are
also capable of degrading the ECM components. This activity is what allows the
MMP family to remodel and repair defective tissues to allow for normal growth.
MMPs are primarily regulated by their natural inhibitors, TIMPs (Cawston,
Billington et al. 1999). This family of metalloproteases has been shown to localize
to the cartilage of patients with arthritis, suggesting their role in inflammatory
diseases (Koolwijk, Miltenburg et al. 1995). Their presence is typically linked to
tissues undergoing remodeling. This is also the case in the joints of horses with
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osteochondritis dissecans, a disease in which there is a loss of blood supply to the
area of bone directly beneath the joint (Al-Hizab, Clegg et al. 2002).
TIMP expression is widespread. TIMP2 expression is constitutive and
widely expressed in many tissue types while the rest of the family members are
inducible proteins and are known to exhibit tissue specificity (Brew,
Dinakarpandian et al. 2000). TIMP1 is enriched in reproductive organ systems;
TIMP3 is enriched in the heart, kidney, and thymus (Leco, Apte et al. 1997;
Crocker, Pagenstecher et al. 2004).
Substrate Activities
ADAMs have many substrates and are known to be involved in activities
such as the shedding of cytokines and cytokine receptors, processing of growth
factors and their receptors. There have been 30+ ADAMs identified to date and
19/30 contain the zinc-binding active consensus site of HExxHxxGxxH (Nagase
and Kashiwagi 2003). One of the best studied ADAMs is ADAM17, better known
as TNFα converting enzyme, TACE (Black 2002). TNFα is one of the most
predominant proinflammatory cytokines studied in modern science. Originally
ADAM17 was found the be the only ADAM capable of processing TNFα in a
TNFα peptide cleavage assay (Black, Rauch et al. 1997; Moss, Jin et al. 1997). It
was then seen that TNFα processing still occurred in ADAM17 deficient mice,
but when an ADAM inhibitor was added to culture this processing stopped,
suggesting that other ADAMs were processing TNFα (Reddy, Slack et al. 2000).
It was later found that both ADAM9 and ADAM10 cleave TNFα peptides in vitro
(Lunn, Fan et al. 1997; Rosendahl, Ko et al. 1997; Roghani, Becherer et al. 1999;
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Amour, Knight et al. 2000). Even though ADAM17 is not the sole ADAM
responsible for TNFα processing it is still known as an important element because
its expression is increased in the inflammatory response (Patel 1999; Colon,
Menchen et al. 2001). ADAM10 and 17 are also known to cleave the
chemoattractant fractalkine which is known to function in both adhesion and
chemoattraction (Rossi and Zlotnik 2000).
ADAMs are also believed to have a role in the degradation of the
extracellular matrix (ECM). ADAM 10 is known to cleave collagen IV in vitro,
and ADAM15 is capable of cleaving collagen and gelatin in vitro (Chubinskaya,
Cs-Szabo et al. 1998; Martin, Eynstone et al. 2002). It has also been proposed that
ADAM15 could degrade ECM either directly through its metalloprotease activity
or indirectly through proteolytic activation of MMPs (Martin, Eynstone et al.
2002). ADAM13 also has a known role in ECM modification in xenopus cranial
neural-crest migration partly due to its ability to cleave fibronectin from the ECM
(Alfandari, Cousin et al. 2001).
ADAMTS proteins are known to function in inflammation, angiogenesis,
and development (Tang and Hong 1999). Aggrecan, one of the major
proteoglycans of cartilage, is the primary target of many ADAMTS proteins
termed aggrecanases. When aggrecan is removed from cartilage the collagen is
left open to attack by the MMP (Pratta, Scherle et al. 2003). The aggrecanase
family is made up of ADAMTS-1, 4, 5, 8, 9, and 15. Of these aggrecanases
ADAMTS4 and 5 are the most studied and the cleavage fragments of aggrecan
are known (Sugimoto, Takahashi et al. 1999; Tortorella, Pratta et al. 2000;
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Tortorella, Malfait et al. 2001). These two are also capable of cleaving the
chondroitin sulfate proteoglycans brevican and versican (Matthews, Gary et al.
2000; Sandy and Verscharen 2001).
The natural substrate of the TIMP family of proteins are other
metalloproteases such as ADAM, ADAMTS and MMPs. TIMP1 and TIMP2 are
able to bind to both pro-MMP9 and pro-MMP2 via their C-terminal hemopexin
like domain (Apte, Olsen et al. 1995; Gomez, Alonso et al. 1997; Olson, Gervasi
et al. 1997; Olson, Bernardo et al. 2000). Binding via the C-terminal domain is the
most common way in which TIMPs interact with the pro-MMPs to regulate them.
TIMP2 and TIMP4 can bind pro-MMP2 and inhibit MMP2 and MT1-MMP
activity (Hernandez-Barrantes, Shimura et al. 2001). The C-terminal domain of
TIMP3 mediates its binding to the ECM while the other members in the TIMP
family are only found in soluble forms (Langton, Barker et al. 1998). TIMP3 is
also able to inhibit several members of the ADAM and ADAMTS families
including ADAM10, ADAMTS4 and 5 (Smith, Kung et al. 1997).
The Matrix Metalloprotease (MMP) family substrate activities are
categorized into six categories. These include the collagenases, gelatinases,
stromelysins, matrilysins, membrane-type MMPs, and then the ‘orphan’ MMPs
which do not fall into any of the above categories. Each subsets name essentially
identifies its substrate. The main family of interest in laminitis is the gelatinase
family due to their known presence in laminitis animals (Kyaw-Tanner and Pollitt
2004; Loftus, Belknap et al. 2006).
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The gelatinases, made up of MMP2 and MMP9, have an additional
fibronectin domain inside the catalytic domain. This domain is potentially
responsible for their ability to digest denatured collagen or gelatin (O'Farrell and
Pourmotabbed 1998). MMP2 is capable of degrading types IV, V, VII, and X
collagen, elastin, fibronectin, laminin, and several chemokines. This MMP is also
capable of activation of proMMP1 and proMMP9 (Yu, Sato et al. 1998). MMP9
also has a type V collagen like sequence between the catalytic and hemopexin like
domains. This MMP is capable of degrading denatured collagen, types IV, V, and
XI collagen, aggrecan, and elastin (Visse and Nagase 2003).
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CHAPTER IV
IMPLICATION OF ADAMs AND RELATED METALLOPROTEASES IN
EQUINE LAMINITIS
Functions of MMPs in Laminitis
Matrix Metalloproteases were first identified as proteins of interest in
laminitis in 1996 when C.C.Pollitt suggested that the expression and activation of
MMPs was the mechanism causing the separation of the epidermal and dermal
laminae (Pollitt 1996). Johnson et al (Johnson, Tyagi et al. 1998) then analyzed
laminae tissue samples from laminitic and non-laminitic horses. This group
discovered that there was gelatinase activity at 92 kDa, 72 kDa, and 66 kDa which
corresponds to MMP9, and MMP2 respectively. This discovery both confirmed
what Pollitt had suggested and initiated a new hypothesis on the overall events
leading to the degradation of the laminae. Previous to this study, work had
focused mainly on the histopathological abnormalities within the epidermal
laminae and not in abnormalities developed in the collagen of the basement
membrane and the ECM of the dermis.
Since this discovery there has been much focus on the involvement of
MMPs in both natural and experimentally induced laminitis. The activation of
endogenous MMP2 and MMP9 activity has been shown to reduce the tensile
strength of laminar explants in vitro (Mungall, Pollitt et al. 1998). MMP2 has also
been shown to be localized to the cytoplasm of the basal and parabasal cells
which are in close proximity to the lamellar basement membrane using in situ
hybridization. Along with that result it was shown that MMP2 mRNA is
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significantly elevated in laminitic horses using qPCR (Kyaw-Tanner and Pollitt
2004). Studies have also been done on the concentrations of collagen IV, a known
target of MMP2 and 9, in horses with laminitis. The results showed that there was
an increase in collagen IV in serum of horses with natural laminitis which
matched up with elevated MMP tissue activity indicated by more gelatin
degradation in a gelatin zymography assay (Johnson, Kreeger et al. 2000). In the
BWE model of laminitis MMP9 increase has been correlated to immigration of
neutrophils into the laminae (Loftus, Belknap et al. 2006). Since neutrophils are
known to store mature MMP9 in their tertiary granules it is not necessary for its
transcription in order to observe its accumulation (Chakrabarti and Patel 2005).
While these are promising data, it is essential to note that gel zymogram do not
reflect the true activity of MMP in vivo as the SDS-PAGE removes the
prodomain artificially activating the enzyme. While these experiments are
indicative of the relative abundance of each MMP, more experiments are needed
to detect active MMP in situ.
Role of ADAMs in Laminitis
ADAMs are known to have a prominent role in both inflammatory disease
and cartilage degradation (Moss and Lambert 2002; Nagase and Kashiwagi 2003).
ADAMs are known to be up regulated at the site of inflammation and their roles
as sheddases is potentially critical during this process. ADAM17 (TACE) is the
most studied ADAM in inflammatory diseases and the exact cleavage sequence is
known (Black, Rauch et al. 1997; Itai, Tanaka et al. 2001; Moss and Lambert
2002). ADAM10 is also known to process pro-TNFα, suggesting it also may
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complement the activities of ADAM17 (Lunn, Fan et al. 1997). Both ADAM10
and 17 are also able to cleave the chemoattractant fractalkine which functions in
both adhesion and chemoattraction (Rossi and Zlotnik 2000). These two ADAM
are therefore likely candidate to be increased in the model of laminitis derived
from inflammation.

The ADAM-TS family of proteases also has a potential role in laminitis
disease progression based on their ability to cleave and process aggrecan, a
proteoglycans found in many ECMs (Nagase and Kashiwagi 2003; Porter, Clark
et al. 2005; Gendron, Kashiwagi et al. 2007). ADAMTS-1, 4, and 5 are all known
aggrecanases and their presence in the laminae could be a critical step is
determining the molecular pathology of laminitis. The presence of these proteases
would suggest that laminitis may bear closer resemblance to arthritis than to any
other human diseases and could have implication in the development of a disease.
The TIMP family of inhibitors is also an interesting target, as the members
of this family are able to inhibit all of the ADAMs mentioned above. The affinity
of certain TIMPs is higher for certain ADAMs so it will be interesting to
determine how the expression levels are changed in each individual case.
The goal of this gene selection is to evaluate how the overall proteolytic
activity may change during the onset and evolution of laminitis.

26

Working Model of Proteolytic Cascade Leading to Degradation of Collagen
and Aggrecan
We have used the knowledge accumulated on MMP and ADAM to draw a
diagram that describes how they may be involved in the degradation of the ECM
Laminae. (Figure 3),. Upon the initial damage it is possible that either ADAM10
or ADAM17 could be activated. These molecules are capable of processing proTNFα to its active form TNFα (Rosendahl, Ko et al. 1997). Once this potent
cytokine has been activated it is capable of activating several pathways which all
ultimately lead to the potential degradation of the laminae. The first of these
pathways is the activation of the ADAMTS family of aggrecanases which could
degrade aggrecan present in the laminae. The second pathway that could be
activated is the MMP pathway. Both MMP2 and 9 are capable of degrading type
IV collagen which is known to be present in the laminae (Kuwano, Ueno et al.
2005). The activation of both families of these proteases could lead to the
separation of the laminae, causing laminitis disease progression. On the other
hand, the TIMP family of protein is able to inhibit many of these pathways at
several points. TIMP3 is capable of inhibiting both ADAM10 and 17, as well as
the ADAMTS family of aggrecanases (Smith, Kung et al. 1997) . TIMP1 is
capable of inhibiting MMP9 and TIMP2 is capable of inhibiting both MMP2 and
9 (Apte, Olsen et al. 1995; Gomez, Alonso et al. 1997; Olson, Gervasi et al.
1997).
In order to test this model we have cloned and sequence members of the
ADAM, ADAMTS, TIMP and MMP family of proteins. We the used these
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sequence to study variation in gene expression during the progression of natural
and artificially induced laminitis.

Figure 3: Model of a proteolytic cascade that could lead to the development of
laminitis.
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CHAPTER V
CLONING OF ADAMs
Cloning and Sequencing of Equine ADAM10, 17, TS4, TS5 and
MMP9
In order to study the role of the ADAM family of proteins in equine
laminitis, ADAM10, ADAM17, ADAM-TS4, and ADAM-TS5 needed to be
cloned. To accomplish this, multiple protein sequence alignments were done for
each gene between several mammalian species in order to determine regions of
homology (Figures 4-7). Degenerated oligonucleotide primers were designed for
each genes most homologous region and are denoted by the boxed sequences in
Figures 4-7. Each of these figures represents a ClustalW alignment of the equine
sequence with three other mammalian species. Identical residues are denoted by
an asterix (*), conservative changes by a double point (:). Also these figures
display the locations of the real time PCR primers which are shown with arrows.
Since ADAMs are known to be expressed in the testis (Wolfsberg, Straight et al.
1995; Kim, Kang et al. 2006) cDNA was made from equine testis tissue. Each
primer set amplified its expected size bands, which were cloned into pCR4-TOPO
(Invitrogen) for sequencing. These results, compared with the human sequences
showed that ADAM10 is 95% identical, ADAM17 is 91% identical, full length
ADAM-TS4 is 90.8% identical, and ADAM-TS5 is 91% identical. Each cloned
sequence corresponded to a different region of domains, which can be seen in
Figures 4-7.
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Figure 4: Amino Acid Sequence Comparison of Equine ADAM10
Single letter amino acid sequence from equine, human, bovine, and mouse
ADAM10 were aligned using ClustalW software. Identical residues denoted by an
asterisk (*), conservative changes are indicated by a double point (:). The
sequence corresponding to the degenerate oligonucleotides are indicated in boxes.
Position corresponding to the oligonucleotide primers used for qRT-PCR
indicated by arrows. The domains are separated by vertical lines.
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Figure 5: Amino Acid Sequence Comparison of Equine ADAM17
Single letter amino acid sequence from equine, human, rat, and mouse ADAM17
were aligned using ClustalW software. Identical residues denoted by an asterisk
(*), conservative changes are indicated by a double point (:). The sequence
corresponding to the degenerate oligonucleotides are indicated in boxes. Position
corresponding to the oligonucleotide primers used for qRT-PCR indicated by
arrows. The domains are separated by vertical lines.
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Figure 6: Amino acid sequence comparison of Equine ADAMTS-4
Single letter amino acid sequence from equine, human, bovine, and mouse
ADAMTS-4 were aligned using ClustalW software. Identical residues denoted by
an asterisk (*), conservative changes are indicated by a double point (:). The
sequence corresponding to the metalloprotease active site is indicated in a box.
The positions corresponding to the oligonucleotide primers used for qRT-PCR are
indicated by arrows. The domains are separated by vertical lines.
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Figure 7: Amino acid sequence comparison of Equine ADAMTS-5
Single letter amino acid sequence from equine, human, bovine, and mouse
ADAMTS-5 were aligned using ClustalW software. Identical residues denoted by
an asterisk (*), conservative changes are indicated by a double point (:). Sequence
corresponding to degenerate oligonucleotides is indicated in a box. Active
metalloprotease site is also labeled and presented in a box. Position corresponding
to oligonucleotide primers used for qRT-PCR is indicated by arrows. The
domains are separated by vertical lines.
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The specific fragments obtained by amplification are shown in Figure 8.
The positions of these primers can also be seen in Figures 4-7. For each of these
primer sets, PCR amplification was performed using no-RT controls, Genomic
DNA, and cDNA samples to test 1) that the cDNA did not contain contaminating
genomic DNA, 2) if the primer could amplify from genomic DNA.

Figure 8: PCR Amplification of +/-RT cDNA Using Specific
Oligonucleotide qPCR Primers
Degenerate primers and those used for the amplification of full length and
partial clones can be found in Table 3. A table that shows the primer efficiencies,
slope and R2 values, as well as the specific melting temperatures of the
amplification product as determined by running a melting curve can be found in
Table 4.
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Table 3: Primer Pairs Used for Specific Gene Amplification and for qRT-PCR

Table 4: qRT-PCR Amplification Efficiencies
Testis cDNA was diluted in 10 fold increments in sterile H2O from a 1:1 to a
1:100 dilution to create templates for the generation of a standard curve for each
gene tested. Efficiencies between 85-110% along with a slope between -3.0 and 4.0 and an R2 value between 0.90 and 1 were acceptable as being equal in
efficiencies.
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Table 5: Oligonucleotide Primer Sets Used for Cloning ADAMs
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CHAPTER VI
EXPRESSION OF ADAM RELATED METALLOPROTEASES
IN BWE INDUCED LAMINITIS
Animals Used
For the BWE experiments, archived samples of laminar tissue from
previous studies were used (Waguespack, Cochran et al. 2004; Waguespack,
Kemppainen et al. 2004; Black, Lunn et al. 2006).

Real Time PCR Results
In the BWE model of laminitis, Table 6A, it was observed that ADAM10
and ADAM17 were more likely to be decreased than increased. ADAM10
expression was decreased in 5/8 animals with 2 animals showing no change and
one animal showing a slight increase at the 3 hour time point. ADAM17 was
decreased in 3/8 animals and no change was seen in 4/8 animals with one animal
showing a slight increase in expression at the 3 hour time point. ADAM-TS1 was
slightly increased in 5/8 animals with the remainder showing no changes in
expression. ADAM-TS4 was the most induced gene of this study and every
animal showed at least a slight increase with most animals (6/8) showing a large
increase in expression. ADAM-TS5 was decreased in this study in 3/8 animals
with the remainder showing no change. MMP9 reduction seemingly occurred at
the early time point of 1.5 hours with 2/2 animals showing a decrease. TIMP1
expression was not seen to change other than 1/8 animals showing a 2.13 fold
increase. TIMP2 expression was reduced in 5/8 animals with no trend towards
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either early or late reduction. Expression of TIMP3 was not changed at the early
time point, however 5/6 animals at the 3 hour and 12 hour time points showed a
reduction in expression.
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CHAPTER VII
EXPRESSION OF ADAM RELATED METALLOPROTEASES
IN CHO INDUCED LAMINITIS
Animals Used
For the CHO experiments, archived samples of lamellae from a previous
study were used (Johnson, Kreeger et al. 2000).

Real Time PCR Results
The CHO model of laminitis, Table 6B, was grouped into animals which
either showed a response to treatment (CHO-R), and those which did not (CHONR). Animals which were in the CHO-R group showed no changes in either
ADAM10 or ADAM17 expression, while there was an increase in expression of
ADAM-TS1. ADAM-TS4 was greatly increased in 3/3 animals in the CHO-R
group, and also in 2/3 animals in the CHO-NR group. ADAM-TS5 expression
was also increased in both the CHO-R and CHO-NR groups with 5/6 animals
showing an increase. MMP9 was consistently induced in all 6/6 animals in the
CHO study. TIMP1 expression was also increased in 5/6 animals in the CHO-R
and CHO-NR groups. TIMP2 was decreased in the CHO-R group while there was
no change seen for the animals in the CHO-NR group. TIMP3 was increased in
all of the horses in the CHO-NR group while there were 2/3 horses with an
increase in the CHO-R group, with the remaining animal showing a decrease in
expression.
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CHAPTER VIII
EXPRESSION OF ADAM RELATED METALLOPROTEASES
IN NATURAL LAMINITIS
Animals Used
The natural laminitis samples were obtained from horses which were
euthanized at the University of Missouri School of Veterinary Medicine Equine
Clinical Center.

Real Time PCR Results
Natural cases of laminitis, Table 6B, share the best correlation of gene
expression with the CHO model. This model had animals grouped into either
acute cases in which the animals had not previously shown signs of laminitis,
animals in the chronic subset had a history of laminitis but had not had any acute
episodes, and animals in the chronic aggravated subset had a history of laminitis
and were experiencing a debilitating episode. All horses, regardless of
classification, showed an increase in ADAM-TS4 expression and 9/11 showed a
decrease in TIMP2 expression. ADAM10 expression was decreased in both the
chronic and chronic aggravated animals (4/8) with the remainder showing no
change in expression. ADAM17 showed no change in expression, with the
exception of one clinical animal having a decrease. ADAM-TS1 only had 3/11
animals with slight increases while ADAM-TS5 expression was increased in
acute cases as well as 5/8 of the chronic and chronic aggravated cases. MMP9
expression was greatly increased in the acute cases of laminitis while there were
6/8 animals with an increase in the chronic and chronic aggravated cases of
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laminitis. Expression of TIMP1 was increased in acute cases while there was
either no change or a decrease in expression in the chronic and chronic aggravated
cases. Expression of TIMP3 was increased in all animals in the clinical cases and
expression ranged from 3.2 to 31.76 fold increase.
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Table 6: Quantative Real Time PCR Results
Real-time quantative PCR was performed on cDNA samples of 32 horses. Each
specific oligonucleotide primer pair was run in triplicate on three different days
using a Roche Lightcycler 2.0. The relative value for each sample was obtained
using the ∆∆Ct method and controlled to expression of GAPDH. Each value was
averaged from triplicates. Numbers between 2 and 10 are highlighted in yellow
and correspond to a 2 to 10 fold increase. Numbers superior to 10 are in red and
correspond to an increase greater than 10 fold. Values inferior to 0.5 are
highlighted in blue and correspond to at least a 2 fold decrease. The horse
number, age, breed, as well as the results for each of the selected genes are
presented. BWE; Black Walnut Extract, CHO; Carbohydrate Overload.
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CHAPTER IX
SUMMARY OF RESULTS
These results show that ADAMs which are known to be associated with
inflammation, ADAM10 and ADAM17, are not significantly increased in horses
with laminitis, regardless of the mode of induction (BWE, CHO, natural) and the
extent of disease. These two genes also clearly act independently of one another,
as it was observed that an increase in one did not necessarily result in an increase
of the other.
The most consistently increased gene in this study, independent of the
mode of induction, was ADAM-TS4 with 24/25 animals showing an increase
which ranged from 2 fold to 333.14 fold increase. The CHO model, acute
laminitis cases, and BWE 3 hour animals all had a significant increase over 10
fold. In many of these cases, the disease was well developed but the increase at
the early BWE time point of 1.5 hours indicates that this ADAM is being induced
before lameness occurs and then remains activated at very high levels throughout
disease progression. TIMP2, the natural inhibitor of MMP2, was decreased in
16/25 horses, which could play a role in the eventual degradation of the laminae
since MMP2 is known to be increased in horses with laminitis (Kyaw-Tanner and
Pollitt 2004). When the observation is limited to horses with clinical signs (12
hour BWE samples, CHO-R, and all clinical cases), 14/17 horses showed a
decrease in TIMP-2. The expression of TIMP1 seemed to be randomly increased
or decreased with no real trends visible. TIMP3 expression was decreased in 5/8
animals in the BWE model while it was increased in 16/17 horses in the CHO and
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clinical cases. This is an interesting fact considering that TIMP3 is an inhibitor of
ADAM10, ADAM17, and ADAM-TS1, 4, and 5. This increase could be a
response of the laminae to try and stop the progression of the disease.
When you look at each induction subset which was investigated the results
are much more interesting considering that the BWE model is known to be a
model of early and reversible laminitis while the CHO model is more like that of
a clinical case of laminitis. In the BWE model Table 6A, ADAM-TS4 was the
only gene that was induced in every animal. MMP9 was initially reduced in the
1.5 hour and 3 hour animals, while TIMP2 was reduced at the later time points of
3 hours and 12 hours. TIMP3 was also reduced in 5/8 horses and its reduction
occurred mainly in the late stage animals. These results, which show that this
model may in fact be an early and reversible form of laminitis, could help to make
use of this model to understand how the reversion of disease is occurring. In this
case, ADAMTS-4 increase would be at the onset of the development of the
disease preceding all other MMP.
In the CHO induction model, Table 6B, there were horses which were
responders, CHO-R, and horses which did not respond to the treatment, CHO-NR.
The CHO-R group showed increased levels of ADAM-TS1, 4, 5, MMP9 and
TIMP1 with a slight decrease in TIMP2 expression. The CHO-NR group had only
1/3 animals with an increase in ADAM-TS1, 2/3 animals with an increase in
ADAM-TS4 and TS5 and all had a similar increase in MMP9. This result
suggests that ADAM-TS4 and TS5 are directly linked to the progression of
laminitis even with the increase of TIMP3 that was observed in 5/6 animals in this
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group. TIMP2 was also reduced in 2/3 CHO-R animals which is similar to the
result which was observed in the BWE model at the late time points.
In the clinical laminitis cases, Table 6B, there was a strong correlation of
results to those observed in the CHO model. All animals in this group showed an
increase of ADAM-TS4 expression from 2.73 to 333.14 fold induction. MMP9
was also increased in this group in 9/11 animals and a decrease in TIMP2 was
observed for 9/11 animals as well. There was no change observed in expression of
ADAM17 with the exception of one animal showing a slight decrease. ADAM10
expression was overall unchanged in the acute and chronic cases of laminitis
while it was decreased in 3/4 of the chronic aggravated animals. TIMP3
expression in this group was seen to increase in all cases of the disease suggesting
that it is potentially being increased in response to the influx of the ADAM-TS
proteins.
A broad overview of these results indicates that there are several key
targets for further study. ADAM-TS4, which is seen to have increased
transcription in 24/25 animals, regardless of the induction method, is a likely
target for the treatment of laminitis. The expression of TIMP2 also brings to
question its importance in the progression of disease considering that it has
decreased expression in 16/25 animals in this study. The high expression levels of
MMP9 are also of interest in this disease, and have been the target of many
studies in the past (Mungall, Pollitt et al. 1998; Mungall and Pollitt 1999; Mungall
and Pollitt 2002; Loftus, Belknap et al. 2006; Loftus, Black et al. 2007). Recent
work on MMP9 suggests that this accumulation of MMP9 is a downstream event
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of the initial inflammation and activation of endothelial cells (Loftus, Black et al.
2007).
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CHAPTER X
DISCUSSION
The initial focus of this project was on ADAM10 and ADAM17 (TACE)
because they are both capable of processing TNFα which is one of the proinflammatory cytokines potentially playing a role in laminitis. The results
obtained showed no real dramatic changes in the expression of these genes in all
modes of induction. Increases observed in both TIMP1 and 3, inhibitors of these
ADAMs, suggests that the activity of these proteins is likely reduced causing a
decrease in TNFα processing. Another study by Belknap et al (Belknap, Giguere
et al. 2007) where TNFα mRNA was measured by qPCR and no significant
increase was observed, suggest that TNFα is not likely to be essential for the
progression of the disease.
Previous work on laminitis has mainly targeted two proteins, MMP2 and
MMP9. These two metalloproteases have been seen in multiple instances to be
increased depending on the mode of induction of laminitis. MMP9 protein was
shown to be induced up to Obel grade 1 lameness in the BWE model (Loftus,
Belknap et al. 2006) and both MMP2 and 9 are induced in the CHO model
(Kyaw-Tanner and Pollitt 2004). The expression of MMP9 mRNA was confirmed
in the CHO model in this study but results are not concrete in the BWE model.It
is possible that the difference observed for MMP9 expression in this study
compared to the previous is the choice of gene selected for the normalization
(GAPDH versus β2-Microglobulin). We are confident that the results obtained in
this study are accurate since in the same conditions, the MMP9 mRNA
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quantification for the CHO was confirmed by a similar increase in MMP9 protein
level obtained from the same horses tested by Dr. Black and colleagues. . One
interesting factor that was common throughout all modes of induction and disease
progression is that TIMP2 was frequently reduced in 16/24 animals. TIMP2 is
responsible for the inhibition of both MMP2 and MMP9 and its decreased
expression could allow for an increase in MMP activity even in the absence of an
increase in MMP mRNA and protein expression in the laminae to cause damage
to the laminae (Gomez, De Lorenzo et al. 1999; Nagase, Visse et al. 2006).
The most obvious gene which was consistently upregulated independently
of the method of induction was ADAM-TS4. This protein is considered to be one
of the main factors involved in cartilage remodeling and osteoarthritis pathology
(Malfait, Liu et al. 2002; Song, Tortorella et al. 2007). In cartilage ADAM-TS4
and 5 cleave aggrecan whose function is to provide a mechanical resistance to
compressive loads. This resistance is provided by the overall negative charges on
the polysaccharide side chains. These negative charges create an osmotic
environment that allows for the high osmotic swelling pressure of cartilage. This
pressure is counteracted by resistance of intact collagen fibers which in turn
creates the high tensile strength.
Aggrecanase in cartilage is known to be induced by several cytokines such as IL1, IL-6, and TNFα (Tortorella, Malfait et al. 2001). There are also reports of its induction
by fibronectin fragments (Homandberg, Meyers et al. 1992; Stanton, Ung et al. 2002). All
of the above cytokines have been observed to be induced in both a BWE and CHO
induction model (Belknap, Giguere et al. 2007) and could be contributing factors to the
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large increase of ADAM-TS4 that was observed. The induction of ADAM-TS4 by
fibronectin or by the previously mentioned cytokines still remains to be determined.
The most potent natural inhibitor of ADAM-TS4 is TIMP3 (Hashimoto,
Aoki et al. 2001). The remaining members of the TIMP family are known to have
a higher affinity for the MMPs (Clegg, Coughlan et al. 1998; Kashiwagi,
Tortorella et al. 2001; Cross, Chandrasekharan et al. 2005). There is clearly an
association between the decrease in TIMP3 and disease progression in the BWE
model (5/8 animals) but this is not as evident in the natural and CHO induced
laminitis cases. There are several animals that had a poor prognosis and a drastic
increase in TIMP3 expression. Even with the increased level of this inhibitor
disease progression is able to continue suggesting that there may be more to
treatment than finding a way to increase transcription of the TIMPs.
Aggrecan is able to protect collagen from degradation by MMPs, but there
are other ECM proteins like fibronectin and thrombospondin that interfere with
ADAM-TS4 access and degradation of aggrecan (Tortorella, Pratta et al. 2000;
Hashimoto, Shimoda et al. 2004). This cooperation could explain why the
development of laminitis needs activation of both ADAM-TS4 and MMPs. With
such a focus on the treatment of arthritis in the past couple of years there have
been several inhibitors developed. These include hydroxamates, P1’
biphenylmethyl substituted inhibitors, to inhibit ADAM-TS proteases (Yao, Chao
et al. 2002; Noe, Natarajan et al. 2005). MMP inhibitors have also been developed
recently and one is highly selective for the inhibition of MMP-2 (Hayashi, Jin et
al. 2007). With all of these tools available as potential treatments for laminitis
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there is clearly a promising area of research to be pursued in both the
development of a clearly defined pathway for laminitis and in finding a way to
inhibit the proteases responsible for cartilage degradation without affecting other
pathways for which these metalloproteases are critical.
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